Healthcare -
Biotechnology - NASDAQ - US
$ 2.89
-1.03 %
$ 1.75 B
Market Cap
-9.03
P/E
GERN - CASH & EQUIVALENTS
Cash & Equivalents GERN - Geron Corporation
70 M
LAST VALUE
41.71%
2 YEAR CAGR
45.21%
5 YEAR CAGR
18.35%
10 YEAR CAGR